Literature DB >> 16416040

Sarcomeric proteins in hypertrophied and failing myocardium: an overview.

Martin M LeWinter1, Peter VanBuren.   

Abstract

This collection of papers covers developments in a rapidly growing area, sarcomeric proteins in hypertrophied and failing myocardium. Advances in our understanding of the biochemistry and biophysics of crossbridge cycling, contributions of thick versus thin filament and the emerging role of titin, the importance and mechanisms of mutations in causing disease, and an integrated understanding of the consequences of sarcomeric protein alterations at the organ level are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416040     DOI: 10.1007/s10741-005-5247-3

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  1 in total

1.  Myofibrillar adenosine triphosphatase activity in congestive heart failure.

Authors:  N R ALPERT; M S GORDON
Journal:  Am J Physiol       Date:  1962-05
  1 in total
  2 in total

1.  C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.

Authors:  Samantha P Harris; Betty Belknap; Robert E Van Sciver; Howard D White; Vitold E Galkin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 2.  The microtubule cytoskeleton in cardiac mechanics and heart failure.

Authors:  Matthew A Caporizzo; Benjamin L Prosser
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.